Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sabien Technology inks invoice facility with chairman's firm

(Sharecast News) - Sabien Technology Group announced on Monday that it would enter into an invoice factoring facility with Parris Group, the family office of its executive chairman Richard Parris, to provide additional working capital as it expanded sales of its M2G Cloud Connect service. The AIM-traded company said the facility, which remained subject to final contract, would advance 80% of the value of invoices assigned by its UK trading subsidiary.

It said the agreement would carry a finance charge of 2.5% per month on any advances, and would be secured by a debenture.

The facility was in addition to funding previously provided by Parris Group announced last August.

As Parris Group is controlled by a company director, the arrangement constituted a related party transaction under the AIM rules.

The independent directors - Ed Sutcliffe, Charles Goodfellow and Ranald McGregor-Smith - said that, after consulting with the company's nominated adviser Allenby Capital, the terms were fair and reasonable for shareholders.

"Sabien thanks Parris Group for its continuing support," said chief financial officer Ed Sutcliffe.

"This facility will enable Sabien to deliver on its existing sales order pipeline, ensuring timely execution and fulfilment of customer commitments.

"It marks a significant step forward in scaling operations to meet growing demand."

At 1438 GMT, shares in Sabien Technology Group were up 3.17% at 7.48p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Chesnara's £260m purchase of HSBC Life UK clears regulatory hurdle
(Sharecast News) - Life and pension consolidator Chesnara has received regulatory approval for its £260m acquisition of HSBC's UK life insurance manufacturing business.
GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Orosur nears completion of Pepas drilling
(Sharecast News) - Orosur Mining said drilling at its Pepas gold prospect in Colombia was nearing completion as the company moves toward an initial NI43-101 compliant mineral resource estimate, while first drill holes at its El Pantano project in Argentina have confirmed the presence of a previously undrilled mineral system.
Botswana Diamonds reports progress in 'difficult year' for industry
(Sharecast News) - Botswana Diamonds reported progress across its exploration portfolio for the year ended 30 June despite what it described as a "very difficult year for the diamond industry", as the AIM-listed company diversified into critical minerals and expanded the use of artificial intelligence in its exploration strategy.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.